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Abstract Stigmatization can exert a variety of pernicious
effects on the lives of persons with mental illnesses. The
purpose of this study was to explore factors related to the
psychosocial impact of stigma among 229 people receiving
psychiatric treatment: 123 with schizophrenia [International
Classification of Diseases, 10th Revision (ICD-10): F20] and
106 with affective disorders (ICD-10: F31–F33). In the
whole sample, the factors most prominently associated with
a greater impact of stigma on personal and family life were
schizophrenia diagnosis, current inpatient treatment, actually
experienced stigma and self-stigma. However, the patterns
of predictors varied between the two diagnostic categories.
For the schizophrenia group, only self-stigma significantly
contributed to a stronger stigma impact. In the affective
group, a more severe impact of stigma was significantly
predicted by inpatient status and experienced stigma. Anti-
stigma programs should address the specific features of
stigmatization associated with various psychiatric diagnoses.
Keywords Stigma impact  Schizophrenia  Affective
disorders  Mental illness  Poland
Introduction
Population surveys carried out across the world reveal that
despite the increase in the public’s mental health literacy,
the level of social rejection of people with mental illnesses
did not change for the better over the last decades, and that
with respect to people with schizophrenia it actually
worsened (Schomerus et al. 2012). Thus, although
numerous efforts have been undertaken globally to eradi-
cate psychiatric stigma (Sartorius and Schulze 2005), it
continues to exert pernicious effects on people with mental
health problems, their families, treatment providers and
whole communities (Corrigan and Kleinlein 2005).
Current theoretical models conceptualize mental health
stigma as a complex phenomenon involving several inter-
related components, such as: stereotypes, prejudice, and
discrimination (Corrigan and Kleinlein 2005), or problems
of knowledge (ignorance or misinformation), problems of
attitudes (prejudice), and problems of behavior (discrimi-
nation) (Thornicroft et al. 2007), or labeling, stereotyping,
separation, emotional reactions, status loss, and discrimi-
nation in a situation where power is exercised (Link et al.
2004). The authors of all these models are in agreement
that stigmatization cannot be fully understood without
taking into account the subjective perspective of people
with mental illness, who play an active and important role
in this process. This subjective perspective is often referred
to as personal stigma, as opposed to public stigma, i.e. the
reaction of the general population towards people with
mental illness. Usually, three main aspects of the personal
stigma of mental illness are distinguished (Brohan et al.
2010; Gerlinger et al. 2013): (1) perceived stigma, i.e. an
individual’s beliefs about the extent to which society
stigmatizes the group to which he/she belongs and him/her
personally as a member of a potentially stigmatized group;
(2) experienced stigma, i.e. actually encountered rejection
and discrimination; and (3) self-stigma or internalized
stigma, i.e. the process of the internalization of stigmatiz-
ing societal attitudes, resulting in fear of discrimination,
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social withdrawal, feelings of shame, guilt, and hopeless-
ness, and a decrease in self-esteem and self-efficacy.
However, a recent review of measures of experiences of
mental illness stigma, prejudice and discrimination found
that some of them also covered elements of personal stigma
which did not clearly fit into the categories of perceived,
experienced and self-stigma (Brohan et al. 2010). Exam-
ples are stigma resistance, positive aspects of mental ill-
ness, impact of stigma, or stressfulness of stigma events.
The authors of this review concluded that it would be
useful to consider these additional constructs. In this paper,
we aim to explore one of them, namely the impact of
stigma as measured by a subscale of the Inventory of
Stigmatizing Experiences (ISE; Stuart et al. 2008). It is
defined by the developers of the ISE as ‘‘the intensity of
psychosocial impact of stigma on major life domains such
as quality of life, family relations, social contacts and self-
esteem’’ (Stuart et al. 2008, p. 194). It is, then, conceived as
a measure of the global effects of stigmatization on an
individual’s personal and family life. While the ways in
which stigma interferes with specific psychosocial out-
comes have already been repeatedly demonstrated (Ger-
linger et al. 2013; Livingston and Boyd 2010), identifying
factors contributing to the overall psychosocial impact of
stigma may constitute a valuable expansion of this body of
knowledge and may further help to guide anti-stigma
programs.
It seems of particular interest to determine how stigma
impact depends on the type of mental illness. It is univer-
sally believed that the burden of stigma is particularly high
among people diagnosed with schizophrenia (Read et al.
2006; Sartorius and Schulze 2005). However, a still growing
amount of evidence indicates that it may also be very harsh
for people with affective disorders (Brohan et al. 2011;
Hawke et al. 2013; Lasalvia et al. 2013). A better under-
standing of the specific features of stigmatization associated
with these two diagnostic categories would enable the
elaboration of more tailor-made interventions that may
prove to be more effective than those focusing on mental
illness in general (Angermeyer and Matschinger 2003).
The specific objectives of the present study were as
follows: a) to examine which socio-demographic and
clinical variables are most prominently related to the
intensity of the impact of stigma reported by people with
mental illnesses; b) to determine how various aspects of
personal stigma (i.e. perceived, experienced or self-stigma)
contribute to the impact of stigma; and c) to investigate the
differences in the magnitude and predictors of stigma
impact between persons with schizophrenia and persons
with affective disorders.
Although our analyses were exploratory in nature, we
stated some preliminary hypotheses. First, based on a
systematic review of the studies of public attitudes, which
revealed that rejection towards people with schizophrenia
is generally more pronounced than towards people with
mood disorders (Angermeyer and Dietrich 2006), we
expected a diagnosis of schizophrenia to predict a higher
impact of stigma. Second, since it has been found in lon-
gitudinal studies that the harmful effects of perceived
stigma on the well-being of people with mental illness are
weaker that those of self-stigma (Ritsher and Phelan 2004)
and are substantially reduced or become non-significant
when actual rejection experiences are controlled for (Link
et al. 1997; Markowitz 1998), we hypothesized that inter-
nalized and experienced stigma would display more robust
relationships with stigma impact than perceived stigma.
Third, we assumed that the impact of stigma would be
greater among respondents with more severe psychiatric
symptoms, which may increase the probability of
encountering social rejection (Farina 1998) and have been
demonstrated to be significantly related to personal stigma
in the majority of relevant studies (Gerlinger et al. 2013;
Livingston and Boyd 2010). Fourth, we reasoned that a
longer duration of illness would be associated with a
greater exposure to stigmatization and, as a result, with its
stronger psychosocial impact. Finally, given that psychi-
atric hospitalization is regarded as an especially stigma-
tizing form of treatment (Falk 2001), we expected that
participants from inpatient wards would report a more
intense impact of stigma than those under outpatient,
community or day care. We made no specific predictions
regarding socio-demographic variables, because in recent
literature reviews (Gerlinger et al. 2013; Livingston and
Boyd 2010) none of them showed consistently significant
associations with personal stigma.
Methods
Sample
Study participants were recruited from various mental
health care facilities of the Institute of Psychiatry and
Neurology (IPiN) in Warsaw (Poland). The inclusion cri-
teria were as follows: (1) diagnosis of schizophrenia (F20)
or affective disorders (F30-F33) according to the criteria of
the International Classification of Diseases, 10th Revision
(ICD-10); (2) age over 18 years old; (3) written, informed
consent to participate in the study; and (4) a stable mental
condition, according to the treating psychiatrist, enabling
understanding and accurate answering of the questions in
the questionnaires. Individuals with active drug or alcohol
dependence, organic brain disease, severe cognitive deficits
or documented mental retardation were excluded.
Out of 281 persons who were asked to participate in the
study, 52 (18.5 %) refused. The final sample included 229
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participants—123 (53.7 %) with schizophrenia and 106
(46.3 %) with affective disorders. In the affective group,
slightly more than a half of respondents (n = 56, 52.8 %)
were diagnosed with bipolar affective disorder (ICD-10:
F31), 12 (11.3 %) had a diagnosis of depressive episode
(ICD-10: F32), and 38 (35.8 %) had experienced recurrent
depressive disorder (ICD-10: F33).
Measures
Socio-demographic and clinical background characteristics
of the participants (including age, sex, level of education,
marital status, living situation, employment status, duration
of illness, and current type of mental health care) were
collected using a self-report questionnaire.
The intensity of psychopathological symptoms was
measured by means of the standard version of the Brief
Psychiatric Rating Scale (BPRS; Overall and Gorham
1988). This instrument consists of 18 items rated by a
clinician on a scale from 1 (symptom not present) to 7
(symptom extremely severe). Summing up individual items
generates a total scale score, which can range from 18 to
126, with higher scores denoting more severe symptoms. In
our study, the values of Cronbach’s alpha coefficients for
the BPRS were .91 in the schizophrenic group, .82 in the
affective group, and .91 in the whole sample.
Various aspects of the personal stigma of mental illness
were evaluated with the use of the Inventory of Stigma-
tizing Experiences—Consumer Version (ISE; Stuart et al.
2008). This self-report instrument includes two separate
scales—the Stigma Impact Scale (SIS) and the Stigma
Experiences Scale (SES). The SIS assesses the severity of
the psychosocial impact of stigma—our main variable of
interest. This subscale is made up of seven items, of which
four ask a respondent how much stigma has affected him/
her personally and three ask to what extent stigma has
affected a respondent’s family as a whole. Items are scored
on an 11-point scale from 0 (reflecting no impact) to 10
(reflecting the highest amount of impact). The sum of all
items renders a total score ranging from 0 to 70, with
higher scores corresponding to greater impact of stigma. In
this study, Cronbach’s alpha coefficient for the SIS was .91
in the schizophrenia group, .96 in the affective group, and
.94 in the total sample. According to the authors of the ISE,
the other subscale, the SES, evaluates the frequency of
stigma experienced. However, a closer analysis of its
content reveals that it is rather a complex measure covering
several distinct dimensions of personal stigma (Brohan
et al. 2010): (1) two items refer to perceived stigma—one
of them addresses stereotype awareness, while the other
addresses personal fear of encountering stigma; (2) two
items concern experienced stigma – one asks about having
been teased, bullied or harassed and the other about having
been treated unfairly or denied rights; (3) one item regards
social withdrawal—a behavioral aspect of self-stigma; (4)
five items ask about the impact of stigma on various life
domains. Two items assessing perceived stigma are scored
on a 5-point Likert-type scale using the response categories
of ‘‘never’’, ‘‘rarely’’, ‘‘sometimes’’, ‘‘often’’ and
‘‘always’’. The response categories for the remaining eight
items are ‘‘no’’, ‘‘unsure’’ and ‘‘yes’’. All ten items inclu-
ded in the SES are recoded into binary variables: 0 = the
absence of stigma (either ‘‘never’’, ‘‘rarely’’ and ‘‘some-
times’’ or ‘‘no’’ and ‘‘unsure’’) and 1 = the presence of
stigma (either ‘‘often’’ and ‘‘always’’ or ‘‘yes’’). Items are
summed up for a total score ranging from 0 to 10, with
higher ratings indicating more stigma. Since, in the current
study, we were interested how specific components of
personal stigma contribute to stigma impact, we selected
for our analyses individual items assessing perceived,
experienced and self-stigma and did not use the total score
of the SES. Five items of the SES concerning the impact of
stigma have been excluded, because their content overlaps
to a significant degree with the content of the SIS.
Procedures
The study was approved by the Bioethical Committee at
the IPiN. In each participating service, eligible individuals
were identified by staff psychiatrists. They were then
approached by the members of the research team, who
invited them to take part in the study. All participants
provided their informed consent.
Statistical Analyses
The analyses were carried out with the aid of IBM SPSS
Statistics version 21 (SPSS Inc., Chicago, IL). For all study
variables, means and standard deviations or percentages, as
appropriate, were calculated. Cronbach’s alpha coefficients
were computed to ascertain the internal consistency reli-
ability of the instruments. Independent sample t tests and
Chi square tests were performed for comparing diagnostic
groups on continuous and categorical variables, respec-
tively. Hierarchical regression models were used in order to
identify factors independently predicting stigma impact as
measured by the total score of the SIS. In these analyses,
socio-demographic and clinical characteristics were
entered as the first set of predictors (Model 1), followed by
stigma-related variables, i.e. dichotomized items of the
SES assessing perceived, experienced and self-stigma
(Model 2). Separate regression analyses were conducted
for the whole sample and for both diagnostic groups.
Multicollinearity was diagnosed by examining the Vari-
ance Inflation Factor (VIF). The VIF values above ten were
assumed as indicative of collinearity between the
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independent variables in the model (Fahrmeir et al. 2013).
In all analyses, P-values of less than .05 were considered to
be statistically significant.
Results
Socio-demographic and clinical characteristics of schizo-
phrenic and affective groups are presented and compared in
Table 1.
The schizophrenic group was younger, included a higher
percentage of males and a lower percentage of married
people. Participants with schizophrenia were also more
likely to be hospitalized in inpatient units at the time of
assessment and had higher levels of psychopathology as
measured by the BPRS. The two diagnostic groups did not
differ significantly with respect to education, living situa-
tion, employment status and duration of illness.
As shown in Table 2, personal stigma was highly pre-
valent among respondents. The most common was self-
stigma (57 % of the total sample), followed by perceived
stigma (47–51 %). Actual stigma experiences were repor-
ted by 22–28 % of the participants. In comparison to the
affective group, schizophrenia group had significantly
higher rates of experienced stigma and self-stigma. No
between-group differences were found in the levels of
perceived stigma.
The mean score (M) on the SIS for the entire sample was
21.21 (standard deviation [SD] = 20.75). The independent
sample t test revealed that people with schizophrenia
reported a significantly higher impact of stigma than people
with affective disorders (M = 28.33, SD = 19.36 vs
M = 12.94, SD = 19.27; t = 6.01, P\ .001). The results
of the multiple regression analyses predicting stigma
impact are displayed in Table 3.
In the whole sample, the factors significantly associated
with a greater impact of stigma were schizophrenia diag-
nosis, current inpatient treatment, experienced stigma
(being teased, bullied or harassed and being treated unfairly
or denied rights), and self-stigma (social withdrawal). A
total of 39.4 % of the variance in stigma impact was
explained (22.7 % by socio-demographic and clinical
variables entered in the first step and an additional 16.7 %
by stigma-related variables entered in the subsequent step).
For the schizophrenia group, only self-stigma (social
withdrawal) significantly contributed to a stronger stigma
Table 1 Socio-demographic
and clinical characteristics of
the participants
ns non-significant
a Including by common law;
b Including separated/divorced,
widowed and never married;
c Including day ward, outpatient











Age in years, mean (SD) 45.90 (15.13) 38.92 (12.87) 54.01 (13.46) t = –8.66 \0.001
Sex
Female, n (%) 142 (62.0) 68 (55.3) 74 (69.8) v2 = 5.10 0.024
Male, n (%) 87 (38.0) 55 (44.7) 32 (30.2)
Education
Primary or vocational, n (%) 37 (16.2) 23 (18.7) 14 (13.2) v2 = 5.42 ns
Secondary, n (%) 94 (41.0) 56 (45.5) 38 (35.8)
Higher, n (%) 98 (42.8) 44 (35.8) 54 (50.9)
Marital status
Marrieda, n (%) 76 (33.2) 24 (19.5) 52 (49.1) v2 = 22.41 \0.001
Non-marriedb, n (%) 153 (66.8) 99 (80.5) 54 (50.9)
Living situation
Living with someone, n (%) 173 (75.5) 93 (75.6) 80 (75.5) v2 = 0.001 ns
Living alone, n (%) 56 (24.5) 30 (24.4) 26 (24.5)
Employment status
Employed, n (%) 89 (38.9) 44 (35.8) 45 (42.5) v2 = 1.07 ns
Not employed, n (%) 140 (61.1) 79 (64.2) 61 (57.5)
Illness duration in years, mean
(SD)
15.36 (12.00) 14.35 (10.71) 16.54 (13.30) t = –1.36 ns
Type of psychiatric setting
Inpatient ward, n (%) 130 (56.8) 84 (68.3) 46 (43.4) v2 = 14.38 \0.001
Otherc, n (%) 99 (43.2) 39 (31.7) 60 (56.6)
BPRS total score, mean (SD) 28.50 (11.07) 33.43 (12.20) 22.82 (5.72) t = 8.55 \0.001
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impact. In the affective group, a more severe impact of
stigma was significantly predicted by inpatient status and
experienced stigma (being treated unfairly or denied
rights). Older age predicted lesser stigma impact among
participants with mood disorders in Model 1, but this
association was no longer significant when stigma-related
variables were introduced into the regression equation.
While as much as 53.5 % of the variance in the dependent
variable was explained in the subgroup with affective
disorders (24.2 % by socio-demographic and clinical
variables and 29.3 % by stigma-related variables), in the
subsample with schizophrenia only 25.2 % of the variance
was accounted for (14.2 % by socio-demographic and
clinical variables and 11 % by stigma-related variables).
The VIF values ranged from 1.09 to 3.17, indicating no
collinearity problems in the models.
Discussion
This study found, as expected, that people with schizo-
phrenia reported greater impact of stigma on personal and
family life than people with affective disorders. Impor-
tantly, this was true even after controlling for socio-
demographic and clinical background characteristics,
severity of psychopathology as well as perceived, experi-
enced and self-stigma. Therefore, the observed difference
in the intensity of stigma impact cannot be totally
accounted for simply by the fact that participants with
schizophrenia were more psychiatrically impaired or that
they internalized stigma and experienced social rejection
more frequently than participants with affective disorders.
Rather, it seems reasonable to hypothesize that persons
with mood disorders may be more resistant to the detri-
mental effects of stigma. This supposition is supported by
the results of the study by Sarisoy et al. (2013), who found
that individuals with bipolar affective disorder had higher
levels of stigma resistance in comparison to those with
schizophrenia. It is recommended that future research
should explore in more detail whether people with various
mental illnesses differentially react to stigma and, if this is
the case, how it affects the psychosocial consequences of
stigma.
Apart from diagnosis, the only clinical variable signifi-
cantly associated with stigma impact in the whole sample
was current type of mental health care. Namely, partici-
pants from inpatient wards reported a stronger impact of
stigma than those under outpatient, community or day care.
Although previous studies yielded inconclusive results
regarding the relationships of personal stigma and type of
psychiatric setting (Gerlinger et al. 2013; Livingston and
Boyd 2010), our finding is consistent with a general con-
viction that psychiatric inpatient hospitalization is a par-
ticularly devastating stigmatization experience (Falk 2001).
Interestingly, when analyzed in the two diagnostic cate-
gories separately, the inpatient status proved to contribute
significantly to the impact of stigma in the affective dis-
orders group, but not in the schizophrenia group. This may
be due to the fact that inpatient wards, in which the data for
this study was collected, are designated primarily to












Perceived stigma Do you think that people will think less of
you if they know you have a mental
illness?a
47.4 50.8 43.4 1.25 ns
Do you think that the average person is afraid
of someone with a serious mental illness?b
51.3 53.3 49.1 0.41 ns
Experienced stigma Have you ever been teased, bullied, or
harassed because you have a mental
illness?c
27.6 35.2 18.9 7.61 0.006
Have you felt that you have been treated
unfairly or that your rights have been
denied because you have a mental illness?d
21.9 28.7 14.2 7.00 0.008
Self-stigma Do you try to avoid situations that may be
stigmatizing to you?e
56.8 63.4 49.1 4.78 0.029
The percentages of participants endorsing SES items refer to those who responded ‘‘often’’ or ‘‘always’’ to items assessing perceived stigma or
‘‘yes’’ to items assessing experienced stigma and self-stigma
ns non-significant
a Short: personal fear of stigma; b short: stereotype awareness; c short: being teased, bullied or harassed; d short: being treated unfairly or denied
rights; e short: social withdrawal
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provide care for people with acute exacerbations and
relapses of psychotic illnesses. It is possible, given this,
that entering such facilities can increase the sense of dif-
ferentness and isolation of persons with mood disorders.
Furthermore, the treatment programs employed in these
settings may better address the needs of persons with
psychosis than those of persons with affective disorders. It
is yet to be investigated whether this is an inpatient hos-
pitalization as such or rather specific characteristics of
inpatient treatment settings that add to the burden of stigma
among people diagnosed with depressive or bipolar
disorders.
As far as stigma-related variables are concerned, expe-
rienced stigma and self-stigma, but not perceived stigma
turned out to be significant predictors of stigma impact in
the entire sample. This pattern of results is not very
surprising, since perceived stigma is regarded as the initial
stage of the process of self-stigmatization, which becomes
harmful only when public stereotypes about people with
mental illness are accepted and internalized by the indi-
vidual (Corrigan et al. 2006). It is more notable that the two
diagnostic groups included in our study differed with
respect to which dimensions of personal stigma contributed
most to the impact of stigma. Among respondents with
schizophrenia stigma impact was significantly predicted
solely by self-stigma, whereas among the affective group it
was experienced stigma that was identified as a crucial
determinant of psychosocial consequences of stigma. This
difference merits further investigation since it may point to
the distinct patterns of personal vulnerability/resilience
factors influencing the effectiveness of dealing with vari-
ous components of personal stigma in either diagnostic
Table 3 Summary of hierarchical multiple regression analyses predicting stigma impact in the whole sample and in the diagnostic subgroups
Predictor Total sample n = 229 Schizophrenia n = 123 Affective disorders n = 106
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Gendera -0.08 -0.02 -0.13 -0.04 -0.09 -0.03
Age -0.12 -0.06 0.04 0.01 -0.26* -0.07
Educationb
Primary or vocational 0.06 0.07 0.15 0.14 -0.01 -0.03
Higher -0.06 -0.06 -0.19 -0.15 -0.01 -0.08
Marital statusc -0.01 0.01 0.13 0.16 -0.20 -0.10
Living situationd 0.04 0.06 0.10 0.11 -0.05 0.04
Employment statuse -0.04 -0.01 -0.03 -0.01 -0.04 0.02
Duration of illness 0.12 0.06 0.15 0.08 0.04 0.04
Type of psychiatric settingf -0.21** -0.16* -0.13 -0.09 -0.30* -0.27*
BPRS total score 0.04 0.08 -0.01 0.02 0.01 0.12
Diagnosisg -0.25** -0.16* – – – –
Stigma-related variables
Personal fear of stigma – 0.08 – -0.01 – 0.08
Stereotype awareness – 0.11 – 0.18 – 0.11
Being teased, bullied or harassed – 0.15* – 0.15 – 0.13
Being treated unfairly or denied rights – 0.20** – 0.13 – 0.42***
Social withdrawal – 0.18** – 0.20* – 0.16
R2 0.227 0.394 0.142 0.252 0.242 0.535
DR2 – 0.167 – 0.110 – 0.293
Standardized regression coefficients (Beta) are presented
BPRS brief psychiatric rating scale
a 0 = Female, 1 = male
b Secondary = reference category
c 0 = Non-married (including separated/divorced, widowed and never married), 1 = married (including by common law)
d 0 = Living with someone, 1 = living alone
e 0 = Not employed, 1 = employed
f 0 = Inpatient ward, 1 = other (including day ward, outpatient clinic and community mental health center)
g 0 = Schizophrenia, 1 = affective disorders
* P\ .05; ** P\ .01; *** P\ .001
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group. Identifying these factors may reveal relevant targets
for programs aimed at reducing the psychosocial harms
caused by stigma among persons with schizophrenia and
mood disorders.
Unexpectedly, the intensity of psychopathological
symptoms and illness duration turned out to be unrelated to
stigma impact. This indicates that the psychosocial impact
of stigma is not a direct consequence of psychiatric
impairment or length of exposure to stigmatizing events.
Our results also confirm the conclusions from two recent
literature reviews (Gerlinger et al. 2013; Livingston and
Boyd 2010) that socio-demographic variables are not
strongly correlated with the personal stigma of mental
illness.
The present study may have relevant practical implica-
tions. The findings add to the extant literature demon-
strating that self-stigma and experienced stigma can
negatively influence personal and family life. Hence,
counteracting their pernicious effects is crucial for the
improvement of the well-being of people with mental
health problems. On the basis of a review of empirical
studies of self-stigma reduction strategies, two prominent
approaches in this area can be recommended: interventions
directed at correcting the stigmatizing beliefs and attitudes
of the individual, and interventions attempting to enhance
the individual’s skills for coping with self-stigma through
improvements in self-esteem, empowerment, and help-
seeking behavior (Mittal et al. 2012). Anti-stigma efforts
should also include interventions aiming to help people
with mental illnesses to work out useful strategies for
dealing with social rejection and a devalued social identity.
From a recent longitudinal study by Ilic et al. (2014), which
tested the effectiveness of a wide array of stigma-coping
strategies, two of them, i.e. selective disclosure and infor-
mation seeking, emerged as the most beneficial: the former
predicted less stigma experiences and both predicted better
mental health at follow-up. In view of these findings, cli-
nicians should assist people with mental health problems in
their decisions about the manner and extent of disclosure
and support them in their efforts to gain better knowledge
and understanding of their illness. If other studies consis-
tently replicate our finding that it is self-stigma that is a
core predictor of stigma impact in schizophrenia, whereas
in mood disorders it is experienced stigma, then this should
be reflected in the main focus of the programs targeting
personal stigma designed for people with these diagnoses.
Our results also point to the importance of the type of
psychiatric care in the stigmatization process and support
the notion that inpatient treatment may have severe adverse
effects. This seems particularly relevant for individuals
with mood disorders. Obviously, there are situations where
inpatient hospitalization cannot be avoided, but in such
cases intensive efforts should be undertaken to minimize its
stigmatizing impact. These should include: first, improving
the quality of inpatient care and increasing patients’ sat-
isfaction with received services by responding to their
needs and preferences, which should be assessed on a
regular basis; and, second, incorporating anti-stigma
interventions into the therapeutic programs delivered in
inpatient facilities.
Several limitations of the current study must be recog-
nized. First of all, the cross-sectional nature of the data
precludes making definitive statements about the direction
of the observed relationships. Our participants were
recruited from just one psychiatric institution, so they may
not be representative of the entire population of people with
mental illness in Poland. Next, in order to increase the
statistical power and reduce the number of analyses needed,
we combined depressive episodes, recurrent depressive
disorders and bipolar disorders into one broad diagnostic
category of affective disorders; in the future, it would be
useful to compare the intensity and correlates of the impact
of stigma among more homogenous diagnostic groups.
Furthermore, our measure of stigma impact has not yet been
fully tested psychometrically. In this study, Cronbach’s
alpha for the SIS was above .90, which may indicate some
redundancy across items (Streiner 2003). It is, then, worth
considering whether the instrument can be shortened. The
SIS still needs to be validated against alternative measures
of the effects that stigma has on persons with mental dis-
orders, such as e.g. the Stigma Stress Scale (Ru¨sch et al.
2009, 2014), which evaluates perceived stigma-related
harm exceeding the perceived coping resources of the
individual. Another limitation is that we used individual
dichotomized items as proxy measures of dimensions of
personal stigma predicting stigma impact. Thus, our find-
ings need to be replicated using more complex, psycho-
metrically robust instruments for the assessment of the
specific elements of personal stigma, such as e.g. the Per-
ceived Devaluation-Discrimination Scale (PDD; Link
1987) for assessing perceived stigma, the Discrimination
and Stigma Scale (DISC; Brohan et al. 2013) for assessing
experienced stigma, or the Internalized Stigma of Mental
Illness Scale (ISMI; Ritsher et al. 2003) for measuring self-
stigma. It should be noted, as well, that our set of predictors
explained twice as much of the variance in stigma impact in
the affective group as it did in the schizophrenia group. This
difference in the predictive value of our models in the two
diagnostic groups raises the possibility that other variables,
which were not included in this research, may play an
important role in modifying the psychosocial impact of
stigma among people with schizophrenia. Some unmea-
sured factors may also have affected the observed differ-
ence in the severity of stigma impact between diagnostic
categories. For example, we did not collect data on the
number of previous inpatient admissions. It is probable that
376 Community Ment Health J (2016) 52:370–378
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participants with schizophrenia had experienced more
hospitalizations in inpatient settings than those with mood
disorders. The same applies to past experiences with com-
pulsory treatment, which has been found to be associated
with various aspects of the personal stigma of mental illness
(Ru¨sch et al. 2014; Thornicroft et al. 2009).
Given the above limitations, our analyses should be
regarded as preliminary and exploratory. Despite this, the
results obtained contribute to a better understanding of the
factors influencing the psychosocial consequences of psy-
chiatric stigma and underscore the role of the type of
mental illness in the process of stigmatization. Researchers
and clinicians elaborating anti-stigma interventions should
take into consideration these factors and address the spe-
cific features of stigma associated with various psychiatric
diagnoses.
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